Guo, Jia et al. show that an FDA-approved Na + /K + - ATPase inhibitor ouabain reduces the burden of Zika virus infection in adult mice while protecting fetal mice from Zika virus infection-induced microcephaly. This study suggests ouabain’s therapeutic potential for Zika virus.
- Jiao Guo
- Xiaoying Jia
- Wei Wang